Related Experiment Videos
Metabolic disorders of embryogenesis
1Department of Biochemistry, University of Oxford, UK.
Insights
Preventing infant malformations requires understanding their causes. Identifying specific enzyme defects linked to developmental anomalies can reveal biochemical bases for teratogenesis, aiding prevention strategies.
Area of Science:
- Developmental Biology
- Medical Genetics
- Biochemistry
Background:
- Major physical malformations contribute significantly to infant mortality and morbidity.
- Understanding pathogenic mechanisms is crucial for developing preventive and therapeutic strategies.
- Single gene defects are estimated to cause up to 10% of major malformations, but few are well-characterized.
Purpose of the Study:
- To highlight the importance of the metabolic environment in normal development.
- To correlate biochemical abnormalities with specific teratogenic effects.
- To advocate for increased metabolic studies in infants with developmental anomalies.
Main Methods:
- Review of existing literature on developmental anomalies and enzyme defects.
- Analysis of patterns linking specific enzyme defects to malformations.
- Correlation of biochemical abnormalities with teratogenic outcomes.
Main Results:
- Specific enzyme defects are associated with characteristic patterns of developmental anomalies.
- The metabolic environment plays a critical role in normal development.
- Biochemical abnormalities can be linked to particular teratogenic effects.
Conclusions:
- Recognizing the biochemical basis of some structural malformations is essential.
- Increased metabolic studies in affected infants can identify new disease examples.
- Elucidating molecular mechanisms of human teratogenesis is a key goal.
Abstract:
Prevention of major physical malformations would represent a significant reduction in the burden of mortality and morbidity in infants and young children. However, preventive and therapeutic approaches must be based on a clear understanding of underlying pathogenic mechanisms. While it is estimated that single gene defects account for up to 10% of cases of major malformation, relatively few of these have been identified and analysed in detail. The recognition of characteristic patterns of developmental anomalies associated with specific enzyme defects has highlighted the important role of the metabolic environment in normal development and offers the possibility of correlating biochemical abnormalities with particular teratogenic effects. Once it is generally appreciated that some forms of structural malformation have a specific biochemical basis, metabolic studies should be performed more often in patients with major developmental anomalies. This should lead to identification of other examples of diseases of this type and the elucidation of molecular mechanisms of human teratogenesis.